MAPT and Alzheimer disease: Similarly, the aa 297–391 fragment has been shown to spontaneously form filamentous aggregates whose structure resembles PHFs in AD patients.[89] Although these truncated tau fragments aggregate without the need for cofactors or harsh conditions, they still differ from the tau aggregates observed in biological samples in morphology, kinetics of formation, and, potentially, functions.